Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule

Journal of Experimental Medicine

Volumn 201, Issue 4, 2005, Pages 535-543

  Rao, Vivek ^a   Fujiwara, Nagatoshi ^b,c   Porcelli, Steven A ^b   Glickman, Michael S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORD FACTOR; CYCLOPROPANE; CYCLOPROPANE SYNTHASE; ENZYME; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MEMBRANE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; GRANULOMATOUS INFLAMMATION; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CELL LINE; COLONY COUNT, MICROBIAL; CORD FACTORS; CYCLOPROPANES; IMMUNITY, NATURAL; INTERLEUKIN-6; MACROPHAGE ACTIVATION; MACROPHAGES; METHYLTRANSFERASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14244260489     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041668     Document Type: Article

References (48)

1. Cosma, C.L., D.R. Sherman, and L. Ramakrishnan. 2003. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57:641-676.
2. Clark-Curtiss, J.E., and S.E. Haydel. 2003. Molecular genetics of Mycobacterium tuberculosis pathogenesis. Annu. Rev. Microbiol. 57:517-549.
3. Smith, I. 2003. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16:463-496.
4. Cox, J.S., B. Chen, M. McNeil, and W.R. Jacobs Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature. 402:79-83.
5. Camacho, L.R., D. Ensergueix, E. Perez, B. Gicquel, and C. Guilhot. 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257-267.
6. Gao, L.Y., F. Laval, E.H. Lawson, R.K. Groger, A. Woodruff, J.H. Morisaki, J.S. Cox, M. Daffe, and E.J. Brown. 2003. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol. Microbiol. 49:1547-1563.
7. Dubnau, E., J. Chan, C. Raynaud, V.P. Mohan, M.A. Laneelle, K. Yu, A. Quemard, I. Smith, and M. Daffe. 2000. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 36:630-637.
8. Glickman, M.S., J.S. Cox, and W.R. Jacobs Jr. 2000. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell. 5:717-727.
9. Barry, C.E., III. 2001. Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. Trends Microbiol. 9:237-241.
10. Glickman, M.S., and W.R. Jacobs, Jr. 2001. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell. 104:477-485.
11. Camacho, L.R., P. Constant, C. Raynaud, M.A. Laneelle, J.A. Triccas, B. Gicquel, M. Daffe, and C. Guilhot. 2001. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276:19845-19854.
12. Beatty, W.L., E.R. Rhoades, H.-J. Ullrich, D. Chatterjee, J.E. Heuser, and D.G. Russell. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic. 1:235-247.
13. Russell, D.G., H.C. Mwandumba, and E.E. Rhoades. 2002. Mycobacterium and the coat of many lipids. J. Cell Biol. 158:421-426.
14. Rhoades, E., F. Hsu, J.B. Torrelles, J. Turk, D. Chatterjee, and D.G. Russell. 2003. Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol. Microbiol. 48:875-888.
15. Schaible, U.E., F. Winau, P.A. Sieling, K. Fischer, H.L. Collins, K. Hagens, R.L. Modlin, V. Brinkmann, and S.H. Kaufmann. 2003. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med. 9:1039-1046.
16. Dutronc, Y., and S.A. Porcelli. 2002. The CD1 family and T cell recognition of lipid antigens. Tissue Antigens. 60:337-353.
17. Flynn, J.L., M.M. Goldstein, J. Chan, K.J. Triebold, K. Pfeffer, C.J. Lowenstein, R. Schreiber, T.W. Mak, and B.R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:561-572.
18. Keane, J., S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, W.D. Schwieterman, J.N. Siegel, and M.M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104.
19. Ehlers, S., S. Kutsch, E.M. Ehlers, J. Benini, and K. Pfeffer. 2000. Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/-mice is dependent on T cells and IL-12. J. Immunol. 165:483-492.
20. Zganiacz, A., M. Santosuosso, J. Wang, T. Yang, L. Chen, M. Anzulovic, S. Alexander, B. Gicquel, Y. Wan, J. Bramson, et al. 2004. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113:401-413.
21. Byrd, T.F. 1997. Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes. J. Clin. Invest. 99:2518-2529.
22. Engele, M., E. Stossel, K. Castiglione, N. Schwerdtner, M. Wagner, P. Bolcskei, M. Rollinghoff and S. Stenger. 2002. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J. Immunol. 168:1328-1337.
23. Indrigo, J., R.L. Hunter Jr., and J.K. Actor. 2003. Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology. 149:2049-2059.
24. Indrigo, J., R.L. Hunter Jr., and J.K. Actor. 2002. Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology. 148:1991-1998.
25. Perez, R.L., J. Roman, S. Roser, C. Little, M. Olsen, J. Indrigo, R.L. Hunter, and J.K. Actor. 2000. Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6′-dimycolate. J. Interferon Cytokine Res. 20:795-804.
26. Yamagami, H., T. Matsumoto, N. Fujiwara, T. Arakawa, K. Kaneda, I. Yano, and K. Kobayashi. 2001. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect. Immun. 69:810-815.
27. Bloch, H. 1950. Studies on the virulence of tubercle bacilli: isolation and biological properties of a constituent of virulent organisms. J. Exp. Med. 91:197-218.
28. Sorkin, E., H. Erlenmeyer, and H. Bloch. 1952. Purification of a lipid material ("cord factor") obtained from young cultures of tubercle bacilli. Nature. 170:124.
29. Asselineau, J., H. Bloch, and E. Lederer. 1953. A toxic lipid component of the tubercle bacillus (cord factor). III. Occurrence and distribution in various bacterial extracts. Am. Rev. Tuberc. 67:853-858.
30. Bloch, H., E. Sorkin, and H. Erlenmeyer. 1953. A toxic lipid component of the tubercle bacillus (cord factor). I. Isolation from petroleum ether extracts of young bacterial cultures. Am. Rev. Tuberc. 67:629-643.
31. Bloch, H., and H. Noll. 1953. Experimental findings on constitution and mode of action of a toxic lipid component of the tubercle bacillus. Trans. Annu. Meet. Natl. Tuberc. Assoc. 49:94-97.
32. Noll, H., and H. Bloch. 1953. A toxic lipid component of the tubercle bacillus (cord factor). II. Occurrence in chloroform extracts of young and older bacterial cultures. Am. Rev. Tuberc. 67:828-852.
33. Mompon, B., C. Federici, R. Toubiana, and E. Lederer. 1978. Isolation and structural determination of a "cord-factor" (trehalose 6,6′ dimycolate) from Mycobacterium smegmatis. Chem Phys. Lipids. 21:97-101.
34. Crowe, L.M., B.J. Spargo, T. Ioneda, B.L. Beaman, and J.H. Crowe. 1994. Interaction of cord factor (alpha, alpha′-trehalose-6,6′-dimycolate) with phospholipids. Biochim. Biophys. Acta. 1194:53-60.
35. Spargo, B.J., L.M. Crowe, T. Ioneda, B.L. Beaman, and J.H. Crowe. 1991. Cord factor (alpha,alpha-trehalose 6,6′-dimycolate) inhibits fusion between phospholipid vesicles. Proc. Natl. Acad. Sci. USA. 88:737-740.
36. Behlmg, C.A., R.L. Perez, M.R. Kidd, G.W. Staton Jr., and R.L. Hunter. 1993. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann. Clin. Lab. Sci. 23:256-266.
37. Chang, Y.Y., and J.E. Cronan Jr. 1999. Membrane cyclopropane fatty acid content is a major factor in acid resistance of Escherichia coli. Mol. Microbiol. 33:249-259.
38. Cronan, J.E., Jr. 2002. Phospholipid modifications in bacteria. Curr. Opin. Microbiol. 5:202-205.
39. Glickman, M.S. 2003. The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid. J. Biol. Chem. 278:7844-7849.
40. Glickman, M.S., S.M. Cahill, and W.R. Jacobs Jr. 2001. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J. Biol. Chem. 276:2228-2233.
41. Yuan, Y., D.C. Crane, J.M. Musser, S. Sreevatsan, and C.E. Barry III. 1997. MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis. J. Biol. Chem. 272:10041-10049.
42. Moody, D.B., B.B. Reinhold, M.R. Guy, E.M. Beckman, D.E. Frederique, S.T. Furlong, S. Ye, V.N. Reinhold, P.A. Sieling, R.L. Modlin, et al. 1997. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 278:283-286.
43. Bean, A.G., D.R. Roach, H. Briscoe, M.P. France, H. Korner, J.D. Sedgwick, and W.J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504-3511.
44. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J.M. Musser, C.E. Barry III, V.H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl. Acad. Sci. USA. 98:5752-5757.
45. Manca, C., M.B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C.E. Barry III, and G. Kaplan. 2004. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72:5511-5514.
46. Reed, M.B., P. Domenech, C. Manca, H. Su, A.K. Barczak, B.N. Kreiswirth, G. Kaplan, and C.E. Barry III. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 431:84-87.
47. Tang, J., M. Hu, S. Lee, and R. Roblin. 2000. A polymerase chain reaction based method for detecting Mycoplasma/Acholeplasma contaminants in cell culture. J. Microbiol. Methods. 39:121-126.
48. Sakaguchi, I., N. Ikeda, M. Nakayama, Y. Kato, I. Yano, and K. Kaneda. 2000. Trehalose 6,6′-dimycolate (Cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages. Infect. Immun. 68:2043-2052.